Severe Acute Respiratory Syndrome
"Severe Acute Respiratory Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A viral disorder characterized by high FEVER, dry COUGH, shortness of breath (DYSPNEA) or breathing difficulties, and atypical PNEUMONIA. A virus in the genus CORONAVIRUS is the suspected agent.
Descriptor ID |
D045169
|
MeSH Number(s) |
C02.782.600.550.200.750 C08.730.730
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Severe Acute Respiratory Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Severe Acute Respiratory Syndrome".
This graph shows the total number of publications written about "Severe Acute Respiratory Syndrome" by people in UAMS Profiles by year, and whether "Severe Acute Respiratory Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2021 | 1 | 1 | 2 | 2020 | 3 | 1 | 4 | 2017 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2014 | 1 | 0 | 1 | 2013 | 1 | 0 | 1 | 2012 | 1 | 0 | 1 | 2011 | 0 | 1 | 1 | 2005 | 1 | 0 | 1 | 2004 | 1 | 0 | 1 | 2003 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Severe Acute Respiratory Syndrome" by people in Profiles over the past ten years.
-
Moiani D, Link TM, Brosey CA, Katsonis P, Lichtarge O, Kim Y, Joachimiak A, Ma Z, Kim IK, Ahmed Z, Jones DE, Tsutakawa SE, Tainer JA. An efficient chemical screening method for structure-based inhibitors to nucleic acid enzymes targeting the DNA repair-replication interface and SARS CoV-2. Methods Enzymol. 2021; 661:407-431.
-
Vilanilam GK, Purushothaman R, Baskaran NP, Vohra I, Raghavan S, Bean B, Sajovitz L. Imaging in Vaping-associated Lung Injury: Beyond the Haze. J Addict Med. 2021 May-Jun 01; 15(3):258-260.
-
Chakhalian D, Shultz RB, Miles CE, Kohn J. Opportunities for biomaterials to address the challenges of COVID-19. J Biomed Mater Res A. 2020 10; 108(10):1974-1990.
-
Reznik SE, Tiwari AK, Ashby CR. Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome? Pharmacol Res. 2020 10; 160:105055.
-
Wander P, Hogan DE, Inamdar S, Benias PC, Haddad F, Andrawes S, Bernstein DE, Sejpal DV, Trindade AJ. Elective endotracheal intubation for urgent gastrointestinal endoscopy among hospitalized patients with SARS-CoV-2. Gastrointest Endosc. 2020 10; 92(4):992-995.
-
Sullivan PS, Sailey C, Guest JL, Guarner J, Kelley C, Siegler AJ, Valentine-Graves M, Gravens L, Del Rio C, Sanchez TH. Detection of SARS-CoV-2 RNA and Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva, and Oropharyngeal Samples. JMIR Public Health Surveill. 2020 04 24; 6(2):e19054.
-
Venkataraman T, Coleman CM, Frieman MB. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection. J Virol. 2017 06 15; 91(12).
-
Taylor JK, Coleman CM, Postel S, Sisk JM, Bernbaum JG, Venkataraman T, Sundberg EJ, Frieman MB. Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference. J Virol. 2015 Dec; 89(23):11820-33.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|